UBS sounds caution on Cochlear prospects in near term
MELBOURNE: Cochlear remains in the exclusive club of ASX-listed shares costing more than $200, with
MELBOURNE: Cochlear remains in the exclusive club of ASX-listed shares costing more than $200, with